JP2023544267A5 - - Google Patents

Info

Publication number
JP2023544267A5
JP2023544267A5 JP2023518094A JP2023518094A JP2023544267A5 JP 2023544267 A5 JP2023544267 A5 JP 2023544267A5 JP 2023518094 A JP2023518094 A JP 2023518094A JP 2023518094 A JP2023518094 A JP 2023518094A JP 2023544267 A5 JP2023544267 A5 JP 2023544267A5
Authority
JP
Japan
Prior art keywords
gene
endogenous
cell line
dhodh
partially
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023518094A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023544267A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/075864 external-priority patent/WO2022058603A1/en
Publication of JP2023544267A publication Critical patent/JP2023544267A/ja
Publication of JP2023544267A5 publication Critical patent/JP2023544267A5/ja
Pending legal-status Critical Current

Links

JP2023518094A 2020-09-21 2021-09-21 治療用タンパク質産生のための高産生性組換えチャイニーズハムスター卵巣細胞株の生成 Pending JP2023544267A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20306068.6 2020-09-21
EP20306068 2020-09-21
PCT/EP2021/075864 WO2022058603A1 (en) 2020-09-21 2021-09-21 Generation of a high producing recombinant chinese hamster ovary cell line for therapeutic protein production

Publications (2)

Publication Number Publication Date
JP2023544267A JP2023544267A (ja) 2023-10-23
JP2023544267A5 true JP2023544267A5 (https=) 2024-10-01

Family

ID=72840426

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023518094A Pending JP2023544267A (ja) 2020-09-21 2021-09-21 治療用タンパク質産生のための高産生性組換えチャイニーズハムスター卵巣細胞株の生成

Country Status (16)

Country Link
US (1) US20240043878A1 (https=)
EP (2) EP4214308B1 (https=)
JP (1) JP2023544267A (https=)
KR (1) KR20230068401A (https=)
CN (1) CN116457468A (https=)
AU (1) AU2021342718A1 (https=)
BR (1) BR112023005002A2 (https=)
CA (1) CA3195524A1 (https=)
ES (1) ES3010648T3 (https=)
HU (1) HUE070250T2 (https=)
IL (1) IL301442A (https=)
MX (1) MX2023003278A (https=)
PL (1) PL4214308T3 (https=)
TW (1) TWI912369B (https=)
WO (1) WO2022058603A1 (https=)
ZA (1) ZA202303597B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12529071B2 (en) 2019-03-19 2026-01-20 Sanofi Selection marker-comprising cell line and uses thereof for protein production

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
KR100267720B1 (ko) 1997-12-29 2001-03-02 박호군 사람 글루타민 합성효소 유전자를 포함하는 발현벡터 및 이를 이용하여 동물세포에서 에리트로포이에틴을 고수율로 생산하는 방법
US20030166201A1 (en) * 2001-04-30 2003-09-04 Jensen Michael C. Selection systems for genetically modified cells
JP5756016B2 (ja) * 2008-10-29 2015-07-29 サンガモ バイオサイエンシーズ, インコーポレイテッド グルタミンシンセターゼ遺伝子の発現を不活性化する方法及び組成物
EP2674495A1 (en) * 2012-06-14 2013-12-18 Sanofi CHO expression system
AU2015334872B2 (en) * 2014-10-23 2021-12-16 Sanofi Novel selection marker for cell transfection and protein production
US12497624B2 (en) * 2018-07-13 2025-12-16 Lonza Ltd Methods for improving production of biological products by reducing the level of endogenous protein
WO2020012446A1 (en) * 2018-07-13 2020-01-16 Enzene Biosciences Limited Double knock-out cho cell line method of its generation and producing therapeutic proteins therefrom
US12529071B2 (en) * 2019-03-19 2026-01-20 Sanofi Selection marker-comprising cell line and uses thereof for protein production
WO2020243642A2 (en) * 2019-05-31 2020-12-03 The Trustees Of Columbia University In The City Of New York Multiply auxotrophic cell line for the production of recombinant proteins and methods thereof
CN110343668B (zh) * 2019-07-23 2021-11-19 珠海联邦制药股份有限公司 一种敲除gs基因的cho细胞株及其制备方法与应用

Similar Documents

Publication Publication Date Title
TWI696700B (zh) 使用具有匿跡性之rna的基因表現系統及含有該rna的基因導入、表現載體
JP6499660B2 (ja) 不死化ブタ肺胞マクロファージ
CN109423496A (zh) 一种细胞中内源性表达rna聚合酶的核酸构建物
CN108642076A (zh) 一种体外DNA-to-Protein(D2P)的合成体系、制剂、试剂盒及制备方法
JPH0838177A (ja) 組換dna分子の作製方法
BR112019013003A2 (pt) micro-organismo do gênero corynebacterium, método para preparar monofosfato de 5?-inosina, composição para produzir monofosfato de 5?-inosina, uso da proteína que consiste na sequência de aminoácidos de seq id no: 1 ou 2 e método para aumentar a exportação de monofosfato de 5?-inosina
JP2010506586A5 (https=)
JP2021511781A5 (https=)
WO2024060461A1 (zh) 适用于酵母先导编辑的双质粒系统及应用、酵母先导编辑方法
WO2023035372A1 (zh) 一种有限自我复制mRNA分子系统、制备方法及应用
Sharifnia et al. Design and development of modified mRNA encoding core antigen of hepatitis C virus: a possible application in vaccine production
Deo et al. Evaluation of self-amplifying mRNA platform for protein expression and genetic stability: Implication for mRNA therapies
JP2023544267A5 (https=)
WO2024230665A1 (zh) Rna聚合酶变体及其应用
CN106191090B (zh) 无抗生素表达外源基因的蓝藻工程菌系统及其制备和应用
CN105695494B (zh) 一种三顺反子表达载体、制备方法及应用
CN105063023B (zh) 一种锌指核酸酶介导的猪mstn基因突变序列及其应用
JP2022526497A5 (https=)
WO2023230991A1 (zh) 新型闭合线性双链dna的体外制备技术
CN110172432A (zh) 一种不依赖vb12的聚球藻pcc 7002工程菌及其构建方法和应用
CA3039037A1 (en) Promoter of hspa5 gene
CN120624547A (zh) 一种cho单克隆细胞株的双基因筛选表达载体及其制备方法和应用
CN115947800B (zh) 优化SARS-COV-2刺突蛋白S1基因、包含该基因的mRNA及应用
JPS63502637A (ja) 誘導性熱ショック及び増幅系
RU2021127370A (ru) Линия клеток, содержащая новый маркер отбора, и ее применение для продуцирования белков